Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Unknown 5

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 40Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 18Rectal Neoplasms 14Lung Neoplasms 13Stomach Neoplasms 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 9Esophageal Squamous Cell Carcinoma 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasm Metastasis 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Adenocarcinoma Of Esophagus 8Ovarian Neoplasms 7Sarcoma 6Neoplasms 6Head and Neck Neoplasms 6Urinary Bladder Neoplasms 5Osteosarcoma 5Liver Neoplasms 5Kidney Neoplasms 4Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Turcot syndrome 3Multiple Myeloma 3Locally Advanced Rectal Cancer 3

Interventions

Bevacizumab 23Sorafenib 20Doxorubicin 14Gemcitabine 11durvalumab 10Oxaliplatin 10Fluorouracil 10Cisplatin 10Capecitabine 9Nivolumab 8pembrolizumab 6Sunitinib 6tremelimumab 5atezolizumab 5Radiofrequency Ablation 5Neoadjuvant Therapy 5Leucovorin 5lenvatinib 4aldesleukin 4Thalidomide 4Radiotherapy 4Radiosurgery 4Everolimus 4Erlotinib Hydrochloride 4Drug Therapy 4Carboplatin 4toripalimab 3regorafenib 3camrelizumab 3apatinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Liver Neoplasms × Neoadjuvant Therapy × Clear all
NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Radboud University Medical Center

Phase 2 Unknown
60 enrolled
Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
54 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01182272 2010-08-16

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
36 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡